SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $18,971,000 | +18.6% | 371,543 | +6.9% | 0.02% | +18.8% |
Q3 2016 | $15,999,000 | +126.1% | 347,425 | +47.9% | 0.02% | +128.6% |
Q2 2016 | $7,076,000 | +83.5% | 234,866 | +95.2% | 0.01% | +75.0% |
Q1 2016 | $3,857,000 | -44.1% | 120,315 | +1.6% | 0.00% | -42.9% |
Q4 2015 | $6,902,000 | +34.1% | 118,389 | -2.7% | 0.01% | +16.7% |
Q3 2015 | $5,148,000 | -60.3% | 121,656 | -31.5% | 0.01% | -53.8% |
Q2 2015 | $12,965,000 | -10.7% | 177,600 | -38.5% | 0.01% | -13.3% |
Q1 2015 | $14,512,000 | +536.8% | 288,917 | +363.9% | 0.02% | +650.0% |
Q4 2014 | $2,279,000 | +91.7% | 62,276 | +65.0% | 0.00% | +100.0% |
Q3 2014 | $1,189,000 | – | 37,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |